Premium
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cance... GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its key drug candidates are OXS-2175, targeting the treatment of triple-negative breast cancer; OXS-4235, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, targets cancer cells expressing the CD19 receptor and CD22 receptor. Its TriKE and TetraKE platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.09 | 4.36893203883 | 2.06 | 2.39 | 2.01 | 24193 | 2.23114661 | CS |
| 4 | -0.45 | -17.3076923077 | 2.6 | 2.66 | 1.9907 | 251605 | 2.37275653 | CS |
| 12 | -0.78 | -26.6211604096 | 2.93 | 4.1 | 1.72 | 506853 | 2.74600677 | CS |
| 26 | -0.2 | -8.51063829787 | 2.35 | 4.1 | 1.72 | 228392 | 2.73889281 | CS |
| 52 | -2.7 | -55.6701030928 | 4.85 | 10.6599 | 1.72 | 465934 | 6.05466663 | CS |
| 156 | -77.65 | -97.305764411 | 79.8 | 112.2 | 1.72 | 280331 | 17.04042677 | CS |
| 260 | -162.85 | -98.696969697 | 165 | 591.993 | 1.72 | 312984 | 99.62240952 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
